The use of etanercept in the treatment of peristomal pyoderma gangrenosum

被引：15
作者：
Kim, F. S. [1 ]
Pandya, A. G. [1 ]
机构：
[1] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2012年 / 37卷 / 04期
关键词：
THERAPY;
D O I：
10.1111/j.1365-2230.2011.04234.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：442 / 443
页数：2
相关论文
共 6 条
  • [1] Clinical features and treatment of peristomal pyoderma grangrenosum
    Hughes, AP
    Jackson, JM
    Callen, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (12): : 1546 - 1548
  • [2] McGowan Joseph Wilson 4th, 2004, J Drugs Dermatol, V3, P441
  • [3] Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept)
    Pastor, N
    Betlloch, I
    Pascual, JC
    Blanes, M
    Bañuls, J
    Silvestre, JF
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (01) : 152 - 153
  • [4] The treatment of pyoderma gangrenosum using etanercept
    Roy, DB
    Conte, ET
    Cohen, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : S128 - S134
  • [5] Tan MH, 2001, ARCH DERMATOL, V137, P930
  • [6] Pharmacological therapy for Wegener's granulomatosis
    White, Eric S.
    Lynch, Joseph P., III
    [J]. DRUGS, 2006, 66 (09) : 1209 - 1228
1